Scientific Program Peer Evaluations
The American Society of Hematology (ASH) is committed to providing high-quality, objective, balanced, scientifically rigorous activities that are free from bias. Efforts have been made to ensure that information presented at this meeting meets these standards. Real-time, peer evaluation of these sessions is intended to validate safeguards already in place and document deviations from the educational planning criteria for continuing medical education activities set by the Accreditation Council for Continuing Medical Education and ASH’s Conflict-of-Interest Policy (if applicable). It is also intended to assess the quality of the science presented in the ASH annual meeting. ASH appreciates your assistance with the peer evaluation process.
Please select the session below that you would like to peer review.
Scientific Program Sessions
- Ad Hoc Scientific Committee on Epigenetics and Genomics
- Joint Session: Scientific Committee on Bone Marrow Failure & Scientific Committee on Blood Disorders in Childhood
- Joint Session: Scientific Committee on Hematopathology and Clinical Laboratory Hematology & Scientific Committee on Stem Cells and Regenerative Medicine
- Scientific Committee on Hematopoiesis
- Scientific Committee on Hemostasis
- Scientific Committee on Immunology and Host Defense
- Scientific Committee on Iron and Heme
- Scientific Committee on Lymphoid Neoplasia
- Scientific Committee on Megakaryocytes and Platelets
- Scientific Committee on Myeloid Biology
- Scientific Committee on Myeloid Neoplasia
- Scientific Committee on Plasma Cell Neoplasia
- Scientific Committee on Red Cell Biology
- Scientific Committee on Thrombosis and Vascular Biology
- Scientific Committee on Transfusion Medicine
- Scientific Committee on Transplantation Biology and Cellular Therapies
Special Scientific Symposia
- Changing the Taxonomy of Aggressive Lymphoma: Ready to Impact Clinical Management?
- Drugging the Undruggable
- Lost in Translation: Overcoming Roadblocks in Translating New Therapeutics to the Clinic
- Machine Learning in Hematology
- Special Symposium on the Basic Science of Hemostasis and Thrombosis
Scientific Spotlight Sessions
Friday Scientific Workshops
- Interplay Between Coagulation and Malignancy
- Hematology and Aging: From Bleeding Disorders to Malignant Hematology
- Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
- Novel Curative Options: Gene-Editing and Gene Therapy for Hemoglobinopathies with a Focus on Sickle Cell Disease
- Innovation in Clinical Trial Design
- Integrative Epidemiology: Translating Epidemiology and Basic Science to Maximize Clinical Impact
- Tumor Immune Interactions in Lymphoid Malignancies
- Myeloid Development
- Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission